Press release
Leber Congenital Amaurosis Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis
Leber Congenital Amaurosis
What Is the Current Leber Congenital Amaurosis Market Size and Its Estimated Growth Rate?
The leber congenital amaurosis industry has experienced sturdy expansion recently. The industry's value is projected to climb from $1.01 billion in 2024 to $1.07 billion in 2025, representing a compound annual growth rate (CAGR) of 6.0%. The growth during the prior period is due to factors such as escalating awareness of uncommon eye conditions, augmented government financing, enhanced diagnostic methods, growth of ophthalmic research hubs, and patient advocacy campaigns.
In the coming years, the market for leber congenital amaurosis is anticipated to witness substantial growth. By 2029, it's projected to reach $1.34 billion, with a Compound Annual Growth Rate (CAGR) of 5.9%. This forecast growth can be attributed to factors such as increasing investment in gene therapy, a rising prevalence of inherited retinal diseases, approvals for innovative treatments by regulatory bodies, growth in clinical trials, and escalating healthcare spending. Dominant trends for the forecast period include the rise of CRISPR-based treatments, heightened collaboration among biotech companies, the advancement of personalized medicine, the proliferation of teleophthalmology, and technological innovation in retinal imaging.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22033
How Are Emerging Segments Shaping the Leber Congenital Amaurosis Market Landscape?
The leber congenital amaurosis market covered in this report is segmented -
1) By Treatment Type: Gene Therapy, Pharmaceutical Drugs, Retinal Prosthesis, Assistive Devices, Other Treatments
2) By Age Of Onset: Congenital Leber Congenital Amaurosis (LCA) (From Birth), Early Childhood Leber Congenital Amaurosis (LCA) (1-5 Years), Late-Onset Leber Congenital Amaurosis (LCA) (6 Years And Above)
3) By Distribution Channel:, Direct Tender, Retail Sales
4) By End User: Hospitals, Specialized Eye Clinics, Ophthalmology Research Centers, Home Care Settings, Other End Users
Subsegments:
1) By Gene Therapy: RPE65 Gene Replacement Therapy, CRISPR-Based Gene Editing, AAV (Adeno-Associated Virus) Vector Therapy, Emerging Experimental Gene Therapies
2) By Pharmaceutical Drugs: Retinoid-Based Therapies, Neuroprotective Agents, Anti-Inflammatory Drugs, Antioxidant Therapies
3) By Retinal Prosthesis: Implantable Retinal Chips, Artificial Retinal Stimulation Devices, Bionic Eye Technology
4) By Assistive Devices: Low Vision Aids, Screen Readers and Braille Devices, Mobility Aids for Vision Impairment
5) By Other Treatments: Stem Cell Therapy, Optogenetics-Based Treatments, Visual Rehabilitation Programs, Nutritional and Dietary Interventions
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22033&type=smp
Which Growth Factors Are Influencing Leber Congenital Amaurosis Market Expansion?
The rising incidence of inherited retinal diseases is anticipated to fuel the leber congenital amaurosis (LCA) market's expansion. Inherited retinal diseases (IRDs) are genetic disorders that impact the retina, a light-sensitive tissue crucial for vision located at the back of the eye. This surge in inherited retinal diseases is due to enhancements in genetic testing, increased awareness and diagnosis, and extended lifespan. Genetic testing advancements have simplified the diagnosis of inherited retinal diseases, leading to the detection of more cases. Leber congenital amaurosis aids in deepening the knowledge of inherited retinal diseases by highlighting genetic mutations and disease processes, which in turn, paves the way for tailor-made therapies and treatments. For example, the UK Parliament's House of Commons Library, a governmental administration in the UK, reported in January 2025 that around 25,000 UK individuals were affected by inherited retinal diseases in 2024, marking a yearly increase of 2%. Therefore, the escalating incidence of inherited retinal diseases lends traction to the growth of the leber congenital amaurosis market.
Who Are the Dominant Players Across Different Leber Congenital Amaurosis Market Segments?
Major companies operating in the leber congenital amaurosis market are Sanofi S.A., Novartis AG, Astellas Pharma Inc., Invitae Corporation, Novelion Therapeutics Inc., Andelyn Biosciences Inc., CD Genomics Inc., Editas Medicine Inc., MeiraGTx Holdings plc, Sangamo Therapeutics Inc., LKC Technologies Inc., Aldeyra Therapeutics Inc., Asper Biogene OÜ, Allergan Inc., ProQR Therapeutics N.V., GenSight Biologics S.A., Ocugen Inc., IVERIC bio Inc. (formerly Ophthotech Corporation), Atsena Therapeutics Inc., HuidaGene Therapeutics Co. Ltd.
What Are the Latest Developing Trends in the Leber Congenital Amaurosis Market?
Key market players in the leber congenital amaurosis industry are focusing on the innovation of solutions like RNA-based treatments for better vision restoration and disease management. RNA-based therapies use RNA molecules to target genetic processes in disease treatment, which range from mRNA vaccines and siRNA therapies to antisense oligonucleotides and RNA aptamers. For instance, Laboratoires Théa S.A.S., a pharmaceutical corporuation from France, debuted Sepul Bio, an independent business division committed to the progress of RNA therapies for hereditary retinal diseases in January 2025. This specifically targets sepofarsen for leber congenital amaurosis 10 (LCA10) and ultevursen for USH2A-associated retinitis pigmentosa. Following the successful first patient dosage in the LUNA Phase 2b clinical trial for ultevursen, Sepul Bio is all set to bring about substantial advancements in treating these uncommon genetic disorders.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/leber-congenital-amaurosis-global-market-report
Which Geographic Regions Are Expected to Dominate the Leber Congenital Amaurosis Market in the Coming Years?
North America was the largest region in the leber congenital amaurosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leber congenital amaurosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Leber Congenital Amaurosis Market?
2. What is the CAGR expected in the Leber Congenital Amaurosis Market?
3. What Are the Key Innovations Transforming the Leber Congenital Amaurosis Industry?
4. Which Region Is Leading the Leber Congenital Amaurosis Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leber Congenital Amaurosis Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis here
News-ID: 4073455 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Leber
Leber Hereditary Optic Neuropathy Treatment Market
Introduction
Leber Hereditary Optic Neuropathy (LHON) is a genetic condition that leads to severe vision loss, primarily affecting young adults. This disorder is caused by mutations in mitochondrial DNA, which impairs the function of retinal ganglion cells. As awareness of LHON has grown, so too has the focus on its treatment options. The LHON treatment market is evolving rapidly, driven by advancements in genetic therapies, pharmaceuticals, and supportive care strategies. This…
Europe Leber Congenital Amaurosis Market 2023 - Growth, Trends, Market Size
The Europe Leber Congenital Amaurosis Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Europe Leber Congenital Amaurosis market. This report explores all the key factors affecting the growth of the global…
MEA Leber Congenital Amaurosis Market Size, Share, Industry, Forecast to 2029
The MEA Leber Congenital Amaurosis Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global MEA Leber Congenital Amaurosis market. This report explores all the key factors affecting the growth of the global…
Leber Congenital Amaurosis Market To Reach USD 89.84 Million by 2029
To elaborate the studies and estimations involved in the supreme Leber Congenital Amaurosis market report, a method of standard market research analysis which is SWOT analysis is put forth. This market report opens the door to acquire knowledge about the Healthcare industry which explains what market definition, classifications, applications, engagements and market trends are. The report makes it effortless to identify the types of consumers, their response and views about…
Leber Congenital Amaurosis Market by Players and Application 2024
Leber Congenital Amaurosis Market: Overview
Leber congenital amaurosis (LCA) is a disorder of eye mainly affects the retina. Retina is the specific tissue at the back of the eye responsible for detection of light and color. People, primarily babies suffering with this disorder have severe visual impairment from the first year of life. The visual impairment because of this disorder likely to be stable for the rest of the life, whereas…
Leber Congenital Amaurosis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Leber Congenital Amaurosis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leber Congenital Amaurosis - Pipeline Review, H1 2017, provides an overview of the Leber Congenital Amaurosis (Genetic Disorders) pipeline landscape.
Leber congenital amaurosis is an eye disorder that primarily affects the retina, which is the…
